Musculoskeletal and Peripheral Nervous System Involvement in a Patient Undergoing Chronic Hemodialysis: A Case Report and Literature Review
PDF
Cite
Share
Request
Case Report
P: 173-178
December 2021

Musculoskeletal and Peripheral Nervous System Involvement in a Patient Undergoing Chronic Hemodialysis: A Case Report and Literature Review

Turk J Osteoporos 2021;27(3):173-178
1. Kırıkkale Yüksek İhtisas Hastanesi, Fiziksel Tıp ve Rehabilitasyon Kliniği, Kırıkkale, Türkiye
2. Lösante Çocuk ve Yetişkin Hastanesi, Fiziksel Tıp ve Rehabilitasyon Kliniği, Ankara, Türkiye
No information available.
No information available
Received Date: 07.07.2020
Accepted Date: 07.01.2021
Publish Date: 28.12.2021
PDF
Cite
Share
Request

ABSTRACT

Musculoskeletal system manifestations in chronic renal insufficiency are caused by complex bone metabolism alterations, which is now described under the umbrella term of chronic kidney disease mineral- and bone-related disorder instead of renal osteodystrophy, and iatrogenic processes related to renal replacement treatment. Musculoskeletal and peripheral nervous system involvement is common, especially in patients with end-stage renal failure who undergo hemodialysis for a long time. This case report presents a patient who is undergoing chronic hemodialysis and is diagnosed with renal osteodystrophy, dialysis amyloidosis, osteoporosis, and uremic neuropathy.

References

1
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013;382:260-72.
2
Süleymanlar G, Utaş C, Arinsoy T, Ateş K, Altun B, Altiparmak MR, et al. A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study. Nephrol Dial Transplant 2011;26:1862-71.
3
Türkiye’de Nefroloji, Diyaliz ve Transplantasyon. TC Sağlık Bakanlığı ve Türk Nefroloji Derneği Ortak Raporu. 2018.
4
Kurer MH, Baillod RA, Madgwick JC. Musculoskeletal manifestations of amyloidosis. A review of 83 patients on haemodialysis for at least 10 years. J Bone Joint Surg Br 1991;73:271-6.
5
Lim CY, Ong KO. Various musculoskeletal manifestations of chronic renal insufficiency. Clin Radiol 2013;68:e397-411.
6
Ramaswamy D, Efthimiou P, Gnanasekharan I, Soni A. Management of musculoskeletal complications in endstage renal disease: an update. Clin Rheumatol 2006;25:440-2.
7
Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis 2016;9:319-28.
8
Eastwood JB, Paizanas M. Renal bone disease. In:Hochberg MC,editors Rheumatology 3rd ed Philadelphia: Elsevier; 2003. p. 2133-8.
9
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1-130.
10
Terzibaşoğlu AM, Pekpak M, Akarırmak Ü. Renal Osteodistrofi. Osteoporoz Dünyasından 2004;10:170-6.
11
Delanaye P, Dubois BE, Jouret F, Krzesinski JM, Moranne O, Cavalier E. Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple? Clin Chim Acta 2013;417:35-8.
12
Murphey MD, Sartoris DJ, Quale JL, Pathria MN, Martin NL. Musculoskeletal manifestations of chronic renal insufficiency. Radiographics 1993;13:357-79.
13
Martin KJ, González EA. Metabolic bone disease in chronic kidney disease. J Am Soc Nephrol 2007;18:875-85.
14
Ureña P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, et al. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 2003;18:2325-31.
15
Gupta R, Mohammed AM, Alenizi EK, Ben Nekhi A. Bone mineral density in Kuwaiti patients with end-stage renal disease. Med Princ Pract 2011;20:156-8.
16
Miller PD. Osteoporosis in patients with chronic kidney disease: Management. UpToDate Accessed Dec 16, 2019.
17
Krishnan AV, Kiernan MC. Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve 2007;35:273-90.
18
Bardin T, Kuntz D, Zingraff J, Voisin MC, Zelmar A, Lansaman J. Synovial amyloidosis in patients undergoing long-term hemodialysis. Arthritis Rheum 1985;28:1052-8.
19
Cotten A, Flipo RM, Boutry N, Cortet B, Chastanet P, Foissac-Gegoux P, et al. Natural course of erosive arthropathy of the hand in patients undergoing hemodialysis. Skeletal Radiol 1997;26:20-6.
20
Camargo CRS, Schoueri JHM, Alves BDCA, Veiga GRLD, Fonseca FLA, Bacci MR. Uremic neuropathy: an overview of the current literature. Rev Assoc Med Bras (1992) 2019;65:469-74.
21
Said G. Uremic neuropathy. Handb Clin Neurol 2013;115:607-12.
22
Kandil MR, Darwish ES, Khedr EM, Sabry MM, Abdulah MA. A community-based epidemiological study of peripheral neuropathies in Assiut, Egypt. Neurol Res 2012;34:960-6.